IPA Insider Trading

Insider Ownership Percentage: N/A
Insider Buying (Last 12 Months): C$80,386.29
Insider Selling (Last 12 Months): C$0.00

ImmunoPrecise Antibodies Insider Trading History Chart

This chart shows the insider buying and selling history at ImmunoPrecise Antibodies by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

ImmunoPrecise Antibodies Share Price & Price History

Current Price: C$0.00
Price Change: +0.30 (1.20%)
As of 10/25/2021 12:05 PM ET

This chart shows the closing price history over time for IPA up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

ImmunoPrecise Antibodies Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
3/27/2024Jennifer Lynne BathSenior OfficerBuy4,211C$1.56C$6,567.90
3/25/2024Jennifer Lynne BathSenior OfficerBuy1,000C$1.54C$1,538.50
3/21/2024Jennifer Lynne BathSenior OfficerBuy3,000C$1.38C$4,140.00
3/18/2024Ilse RoodinkSenior OfficerBuy200C$1.43C$285.58
12/20/2023Jennifer Lynne BathSenior OfficerBuy2,000C$1.35C$2,698.40
12/18/2023Mitchell LevineDirectorBuy10,000C$1.38C$13,834.00
12/8/2023Jennifer Lynne BathSenior OfficerBuy20,000C$1.00C$20,000.00
11/9/2023Dirk WittersDirectorBuy1,000C$1.70C$1,700.00
11/1/2023Jennifer Lynne BathSenior OfficerBuy1,000C$2.07C$2,066.60
10/27/2023Dirk WittersDirectorBuy950C$1.82C$1,729.00950
10/26/2023Kristin TaylorSenior OfficerBuy5,000C$1.35C$6,750.00
10/25/2023Barry Alan SpringerDirectorBuy10,000C$1.41C$14,090.00
10/23/2023Jennifer Lynne BathSenior OfficerBuy900C$1.24C$1,115.91
9/22/2023Jennifer Lynne BathSenior OfficerBuy1,000C$1.98C$1,980.40
9/18/2023Jennifer Lynne BathSenior OfficerBuy1,000C$1.89C$1,890.00
3/21/2023Frederic ChabotDirectorBuy605C$2.99C$1,808.95
9/23/2022Gregory Stuart SmithDirectorBuy3,500C$5.41C$18,935.0042,500
9/22/2022Jennifer Lynne BathSenior OfficerBuy500C$6.01C$3,005.6498,798
9/20/2022Jennifer Lynne BathSenior OfficerBuy100C$6.49C$648.9398,098
9/15/2022Jennifer Lynne BathSenior OfficerBuy44C$6.45C$283.7994,942
8/17/2022Jennifer Lynne BathSenior OfficerBuy200C$7.42C$1,483.4794,398
8/15/2022Gregory Stuart SmithDirectorBuy5,000C$6.93C$34,670.0039,000
8/15/2022Jennifer Lynne BathSenior OfficerBuy100C$7.04C$703.7793,398
8/12/2022Jennifer Lynne BathSenior OfficerBuy400C$7.13C$2,850.9091,098
8/9/2022Jennifer Lynne BathSenior OfficerBuy5C$5.41C$27.0387,703
8/4/2022Jennifer Lynne BathSenior OfficerBuy200C$5.22C$1,044.4887,348
8/1/2022Ilse RoodinkSenior OfficerBuy100C$5.56C$555.521,042
5/11/2022Jennifer Lynne BathSenior OfficerBuy50C$5.76C$287.9543,682
5/9/2022Jennifer Lynne BathSenior OfficerBuy299C$6.24C$1,865.7642,631
5/4/2022Jennifer Lynne BathSenior OfficerBuy90C$7.28C$655.1342,049
4/27/2022Jennifer Lynne BathSenior OfficerBuy250C$7.09C$1,771.6541,584
4/22/2022Jennifer Lynne BathSenior OfficerBuy100C$7.21C$720.7240,604
4/11/2022Jennifer Lynne BathSenior OfficerBuy600C$7.27C$4,362.1238,904
4/6/2022Carla Cherry DahlSenior OfficerBuy10,000C$7.49C$74,875.0010,000
4/1/2022Jennifer Lynne BathSenior OfficerBuy100C$6.31C$631.2536,584
2/11/2022Jennifer Lynne BathSenior OfficerBuy300C$6.70C$2,009.7828,934
12/29/2021Jennifer Lynne BathSenior OfficerBuy300C$6.95C$2,086.0420,734
See Full Table

SEC Filings (Institutional Ownership Changes) for ImmunoPrecise Antibodies (TSE:IPA)

IPA is an innovation-driven, technology platform company that supports its pharmaceutical and biotechnology company partners in their quest to discover and develop novel, therapeutic antibodies against all classes of disease targets. The Company aims to transform the conventional, multi-vendor, product development model by bringing innovative and high-throughput, data-driven technologies to its partners, incorporating the advantages of diverse antibody repertoires with the Company's therapeutic antibody discovery suite of technologies, to exploit antibodies of broad epitope coverage, multiple antibody formats, valency and size, and to discover antibodies against multiple/rare epitopes.
Read More on ImmunoPrecise Antibodies

Today's Range

Now: N/A

50 Day Range

MA: N/A

52 Week Range

Now: N/A

Volume

N/A

Average Volume

N/A

Market Capitalization

N/A

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Who are the company insiders with the largest holdings of ImmunoPrecise Antibodies?

ImmunoPrecise Antibodies' top insider investors include:
  1. Jennifer Lynne Bath (Senior Officer)
  2. Gregory Stuart Smith (Director)
  3. Carla Cherry Dahl (Senior Officer)
  4. Ilse Roodink (Senior Officer)
  5. Dirk Witters (Director)
  6. Barry Alan Springer (Director)
  7. Frederic Chabot (Director)
  8. Kristin Taylor (Senior Officer)
  9. Mitchell Levine (Director)
Learn More about top insider investors at ImmunoPrecise Antibodies.